Cv Sciences Inc
(CVSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,141 | -5,661 | -3,760 | -1,533 | -12,233 |
| Depreciation Amortization | 1,750 | 1,322 | 816 | 428 | 1,851 |
| Accounts receivable | 70 | 68 | 5 | 2 | -588 |
| Accounts payable and accrued liabilities | -355 | -140 | 53 | 105 | 531 |
| Other Working Capital | 1,085 | 878 | 739 | 413 | -1,929 |
| Other Operating Activity | 9,537 | 2,104 | 1,242 | 473 | 8,160 |
| Operating Cash Flow | $-2,054 | $-1,429 | $-906 | $-112 | $-4,208 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -17 | N/A | N/A | -114 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -250 |
| Other Investing Activity | 860 | 0 | 0 | 0 | -1,379 |
| Investing Cash Flow | $853 | $-17 | $N/A | $N/A | $-1,743 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 801 | 1,975 | 801 | 801 | 178 |
| Debt Issued | 1,975 | 801 | 1,975 | 0 | 1,508 |
| Debt Repayment | -612 | -612 | -612 | -612 | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 2,520 |
| Other Financing Activity | -424 | -389 | -369 | -60 | -39 |
| Financing Cash Flow | $1,740 | $1,776 | $1,796 | $130 | $4,167 |
| Beginning Cash Position | 519 | 519 | 519 | 519 | 2,302 |
| End Cash Position | 1,058 | 847 | 1,408 | 536 | 519 |
| Net Cash Flow | $539 | $329 | $890 | $18 | $-1,784 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,054 | -1,429 | -906 | -112 | -4,208 |
| Capital Expenditure | -17 | -17 | N/A | N/A | -114 |
| Free Cash Flow | -2,071 | -1,447 | -906 | -112 | -4,322 |